Voltaren Ophtha CD
Voltaren Ophtha CD is a medicine authorised by Swissmedic under authorisation number 55864. The authorisation holder is OmniVision AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 May 2002 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 55864 |
|---|---|
| Name | Voltaren Ophtha CD |
| Full name | Voltaren Ophtha CD, Augentropfen |
| Authorisation holder | OmniVision AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 15 May 2002 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Voltaren Ophtha CD, Augentropfen | B | 15 May 2002 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Voltaren Ophtha CD authorised in Switzerland?
Yes. Voltaren Ophtha CD is authorised by Swissmedic under authorisation number 55864, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Voltaren Ophtha CD have?
Voltaren Ophtha CD is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Voltaren Ophtha CD?
The authorisation holder is OmniVision AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.